Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-03-03
1993-08-24
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514558, 514947, A61K 3144, A61K 3120
Patent
active
052389448
ABSTRACT:
Pharmaceutical formulations and adhesive-coated sheet materials for the topical and/or transdermal delivery of 1-isobutyl-1H-imidazo[4,5-c]-quinolin-4-amine, including creams, ointments and pressure-sensitive adhesive compositions. Pharmacological methods of using the formulations and the adhesive-coated sheet materials of the invention in the treatment of viral infections.
REFERENCES:
patent: 4411893 (1983-10-01), Johnson et al.
patent: 4689338 (1987-08-01), Gerster
patent: 4695465 (1987-09-01), Kigasawa et al.
patent: 4722941 (1988-02-01), Eckert et al.
patent: 4746515 (1988-05-01), Cheng et al.
patent: 4751087 (1988-06-01), Wick
patent: 4863970 (1989-09-01), Patel et al.
patent: 4908389 (1990-03-01), Mahjour et al.
J. Pharm. Sci., 1984 (73) 1153 E. R. Cooper.
Yu et al. Pharm. Research (5), 457, 1988.
Loftsson et al. Pharm. Research (4) 346, 1987.
Chien et al. Pharm Research (5) 103, 1988.
Drug Dev. and Ind. Pharmacy, 1987 (13), 2363 Bharguva.
The Theory and Practice of Industrial Pharmacy Lachman, 2nd edition (1976) pp. 220-229.
Berge Stephen M.
Mitra Amit K.
Nelson Gregory R.
Schultz Helen J.
Wick Steven M.
Griswold Gary L.
Henley III Raymond J.
Kirn Walter N.
Reedich Douglas E.
Riker Laboratories Inc.
LandOfFree
Topical formulations and transdermal delivery systems containing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical formulations and transdermal delivery systems containing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical formulations and transdermal delivery systems containing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-829491